Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada

Total article views   HTML views PDF downloads Totals
3,884 Dovepress* 3,543+ 122 3,665
PubMed Central* 341 164 505
Totals 3,884 286 4,170
*Since 3 December 2021

View citations on PubMed Central and Google Scholar